QTU
|
1 × 10−4
|
L/min |
Tumor blood flow [7] |
LTU
|
4 × 10−6
|
L/min |
Tumor lymph flow [7] |
ClupTU
|
8.18 × 10−9
|
L/min |
Initial tumor uptake clearance [14] |
σTUV
|
0.734 |
- |
Tumor vascular reflection coefficient [7] |
σTUL
|
0.2 |
- |
Lymph reflection coefficient [7] |
ClTU
|
8.96 × 10−9
|
L/min |
Initial clearance from endothelial space [14] |
KDFcRn
|
7.5 × 10−7
|
M–1
|
FcRn-mAb KD [7] |
CFcRn
|
1.64 × 10−5
|
M |
Tumor FcRn concentration [14] |
FR |
0.715 |
- |
Fraction of FcRn bound antibody recycled [7] |
kgrowth |
8.08 × 10−5
|
min–1
|
Tumor growth rate [7] |
VITU
|
1.38 × 10−4
|
L |
Initial Interstitial Volume [14] |
VETU
|
1.25 × 10−6
|
L |
Initial Endothelial Volume [14] |
VVTU
|
1.75 × 10−5
|
L |
Initial Vasculature Volume [14] |
KDEGFR
|
1.5 × 10−10
|
M–1
|
Cetuximab-EGFR KD [4] |
Kint |
1.38 × 10−3
|
min–1
|
EGFR Internalization Rate [65,66] |
ClTMD
|
Kint × VITU
|
L/min |
Cetuximab Bound EGFR Clearance |
CEGFR (NCI-N87) |
1.14 × 10−7
|
M |
EGFR Tumor Concentration [67,68,69] |
CEGFR (Panc-1) |
9.24 × 10−8
|
M |
EGFR Tumor Concentration [70] |
CEGFR (LS174T) |
3.53 × 10−8
|
M |
EGFR Tumor Concentration [67,68] |